These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7695475)

  • 1. New no-donors with antithrombotic and vasodilating activities, X: Antiplatelet and antithrombotic effects of 3-methylsydnone-5-nitrosimine (RE 2047) in combination with ASA, pentoxifylline, and ticlopidine.
    Rehse K; Ciborski T
    Arch Pharm (Weinheim); 1995 Jan; 328(1):71-8. PubMed ID: 7695475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVI: Antiplatelet and antithrombotic effects of the oligoamine RE 1492 in combination with standard and future antithrombotic drugs.
    Rehse K; Ciborski T
    Arch Pharm (Weinheim); 1995 Apr; 328(4):333-7. PubMed ID: 7611829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
    Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z
    J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Viagra with the NO donors molsidomine and RE 2047 with regard to antithrombotic and blood pressure lowering activities.
    Rehse K; Scheffler H; Reitner N
    Arch Pharm (Weinheim); 1999 May; 332(5):182-4. PubMed ID: 10366905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
    Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
    Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761).
    Kim YS; Pyo MK; Park KM; Park PH; Hahn BS; Wu SJ; Yun-Choi HS
    Thromb Res; 1998 Jul; 91(1):33-8. PubMed ID: 9700851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Momo K; Someya K; Tachiiri T; Mitsuoka Y; Nakamura K; Imai S; Ino T; Ohkubo H
    Arzneimittelforschung; 1992 Jan; 42(1):32-9. PubMed ID: 1586377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of ticlopidine and aspirin, administered alone and in combination, on thrombus formation in rat cerebral vessels.
    Sasaki Y; Ishii I; Giddings JC; Yamamoto J
    Haemostasis; 1996; 26(3):150-6. PubMed ID: 8738589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.
    Herbert JM; Dol F; Bernat A; Falotico R; Lalé A; Savi P
    Thromb Haemost; 1998 Sep; 80(3):512-8. PubMed ID: 9759636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.
    Rehse K; Ciborski T; Lüdtke E
    Arch Pharm (Weinheim); 1994 Dec; 327(12):771-7. PubMed ID: 7872854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New NO-donors with antithrombotic and vasodilating activities, I: 3-Arylalkyl-N-nitroso-5-sydnone imines.
    Rehse K; Kämpfe M; Schleifer KJ
    Arch Pharm (Weinheim); 1993 Aug; 326(8):483-7. PubMed ID: 8215847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
    Vilahur G; Casaní L; Badimon L
    Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies.
    Perzborn E; Heitmeier S; Laux V
    J Cardiovasc Pharmacol Ther; 2015 Nov; 20(6):554-62. PubMed ID: 25848131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New NO donors with antithrombotic and vasodilating activities, part 25. Hydroxylamine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Nov; 331(11):365-7. PubMed ID: 9881060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
    Han BH; Suh DY; Yang HO; Park YH; Kang YH; Kim YC
    Arzneimittelforschung; 1994 Oct; 44(10):1122-6. PubMed ID: 7818584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive antithrombotic effect of ASP6537, a selective cyclooxygenase (COX)-1 inhibitor, in combination with clopidogrel in guinea pigs.
    Sakata C; Suzuki KI; Morita Y; Kawasaki T
    Eur J Pharmacol; 2017 Mar; 798():72-76. PubMed ID: 28095326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effect of ticlopidine in a platelet-independent model of venous thrombosis.
    Bernat A; Vallée E; Maffrand JP; Roncucci R
    Thromb Res; 1985 Jan; 37(2):279-85. PubMed ID: 3975872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.